Track the Unichem Laboratories Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Unichem Laboratories Limited has logged 34 insider filings. Market capitalisation: €36.1bn. The latest transaction was disclosed on 10 October 2023 (Sale). Among the most active insiders: ANAND Y MAHAJAN. All data is accessible without an account.
34
Insider Decl.
n/a
Thresholds
€68m
2 ops.
Buy Volume
€105m
32 ops.
Sell Volume
10Σ signal
Buys €68m€105m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,716 of 28,932 companies
61.4
score / 100
Value
57
Quality
66
FCF yld-3.3%
Earn yld7.0%
EV/EBITDA9.2x
ROE9.8%
Gross mgn46%
Net mgn12%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,750 shares@ ₹371.8614.7% of flowEquity SharesSEBI:79ac3ff966f9c10b4d22f932ef6778ad0a4042ba
25 of 34 declarations
About Unichem Laboratories Limited
Unichem Laboratories Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.